Gedeon Richter, Actavis report positive top line results from cariprazine Phase III trial

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

Similar threads

E
FDA receives Actavis' NDA resubmission for cariprazine Actavis plc (NYSE: ACT) and Gedeon...
Replies
0
Views
37
EGBOT
E
E
ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV...
Replies
0
Views
34
EGBOT
E
E
Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis...
Replies
0
Views
62
EGBOT
E

Latest threads

Back
Top